NCT00291499View on ClinicalTrials.gov

Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

August 31, 2010

Conditions
Osteoarthrosis
Interventions
DRUG

Chondroitin 4&6 sulfate (Condrosulf)

800 mg/day for 6 months

OTHER

Placebo

800 mg placebo/day for 6 months

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT00291499 - Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand | Biotech Hunter | Biotech Hunter